85 related articles for article (PubMed ID: 20533531)
41. [Gene therapy for breast cancer].
Takahashi S; Sugimoto Y
Nihon Rinsho; 2005 Mar; 63(3):476-82. PubMed ID: 15773348
[TBL] [Abstract][Full Text] [Related]
42. Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells.
Calmels B; Ferguson C; Laukkanen MO; Adler R; Faulhaber M; Kim HJ; Sellers S; Hematti P; Schmidt M; von Kalle C; Akagi K; Donahue RE; Dunbar CE
Blood; 2005 Oct; 106(7):2530-3. PubMed ID: 15933056
[TBL] [Abstract][Full Text] [Related]
43. Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo.
Pfutzner W; Terunuma A; Tock CL; Snead EK; Kolodka TM; Gottesman MM; Taichman L; Vogel JC
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13096-101. PubMed ID: 12235361
[TBL] [Abstract][Full Text] [Related]
44. The MDS1-EVI1 gene complex as a retrovirus integration site: impact on behavior of hematopoietic cells and implications for gene therapy.
Métais JY; Dunbar CE
Mol Ther; 2008 Mar; 16(3):439-49. PubMed ID: 18227842
[TBL] [Abstract][Full Text] [Related]
45. [Gene therapy for relapsed breast cancer].
Takahashi S; Sugimoto Y
Nihon Rinsho; 2006 Mar; 64(3):563-9. PubMed ID: 16529050
[TBL] [Abstract][Full Text] [Related]
46. [Protection of mdr1 transfected cord blood mononuclear cell graft against anticancer agents in vivo].
An SH; Jin XQ; Xie QL; Kang Q; Wang Y; Zhen SF
Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):82-5. PubMed ID: 15921623
[TBL] [Abstract][Full Text] [Related]
47. Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy.
Moscow JA; Huang H; Carter C; Hines K; Zujewski J; Cusack G; Chow C; Venzon D; Sorrentino B; Chiang Y; Goldspiel B; Leitman S; Read EJ; Abati A; Gottesman MM; Pastan I; Sellers S; Dunbar C; Cowan KH
Blood; 1999 Jul; 94(1):52-61. PubMed ID: 10381498
[TBL] [Abstract][Full Text] [Related]
48. Gene therapy for breast cancer. --Review of clinical gene therapy trials for breast cancer and MDR1 gene therapy trial in Cancer Institute Hospital.
Takahashi S; Ito Y; Hatake K; Sugimoto Y
Breast Cancer; 2006; 13(1):8-15. PubMed ID: 16518057
[TBL] [Abstract][Full Text] [Related]
49. Drug selection with paclitaxel restores expression of linked IL-2 receptor gamma -chain and multidrug resistance (MDR1) transgenes in canine bone marrow.
Licht T; Haskins M; Henthorn P; Kleiman SE; Bodine DM; Whitwam T; Puck JM; Gottesman MM; Melniczek JR
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3123-8. PubMed ID: 11867757
[TBL] [Abstract][Full Text] [Related]
50. Multiarm high-throughput integration site detection: limitations of LAM-PCR technology and optimization for clonal analysis.
Harkey MA; Kaul R; Jacobs MA; Kurre P; Bovee D; Levy R; Blau CA
Stem Cells Dev; 2007 Jun; 16(3):381-92. PubMed ID: 17610368
[TBL] [Abstract][Full Text] [Related]
51. Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis.
Modlich U; Kustikova OS; Schmidt M; Rudolph C; Meyer J; Li Z; Kamino K; von Neuhoff N; Schlegelberger B; Kuehlcke K; Bunting KD; Schmidt S; Deichmann A; von Kalle C; Fehse B; Baum C
Blood; 2005 Jun; 105(11):4235-46. PubMed ID: 15713797
[TBL] [Abstract][Full Text] [Related]
52. Cellular barcoding tool for clonal analysis in the hematopoietic system.
Gerrits A; Dykstra B; Kalmykowa OJ; Klauke K; Verovskaya E; Broekhuis MJ; de Haan G; Bystrykh LV
Blood; 2010 Apr; 115(13):2610-8. PubMed ID: 20093403
[TBL] [Abstract][Full Text] [Related]
53. [Internal Ribosomal Entry Site-Mediated Expression of Human Multidrug Resistance 1 Gene in Human CD34(+) Cells].
Zhu FL; Pan LY; Zhang Y; Sun JM; Liu HZ; Mao N
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Dec; 9(4):323-326. PubMed ID: 12578572
[TBL] [Abstract][Full Text] [Related]
54. High efficiency restriction enzyme-free linear amplification-mediated polymerase chain reaction approach for tracking lentiviral integration sites does not abrogate retrieval bias.
Wu C; Jares A; Winkler T; Xie J; Metais JY; Dunbar CE
Hum Gene Ther; 2013 Jan; 24(1):38-47. PubMed ID: 22992116
[TBL] [Abstract][Full Text] [Related]
55. Tracking of specific integrant clones in dogs treated with foamy virus vectors.
Ohmine K; Li Y; Bauer TR; Hickstein DD; Russell DW
Hum Gene Ther; 2011 Feb; 22(2):217-24. PubMed ID: 20738155
[TBL] [Abstract][Full Text] [Related]
56. Evaluating a ligation-mediated PCR and pyrosequencing method for the detection of clonal contribution in polyclonal retrovirally transduced samples.
Brugman MH; Suerth JD; Rothe M; Suerbaum S; Schambach A; Modlich U; Kustikova O; Baum C
Hum Gene Ther Methods; 2013 Apr; 24(2):68-79. PubMed ID: 23384086
[TBL] [Abstract][Full Text] [Related]
57. Efficient characterization of retro-, lenti-, and foamyvector-transduced cell populations by high-accuracy insertion site sequencing.
Schmidt M; Glimm H; Wissler M; Hoffmann G; Olsson K; Sellers S; Carbonaro D; Tisdale JF; Leurs C; Hanenberg H; Dunbar CE; Kiem HP; Karlsson S; Kohn DB; Williams D; Von Kalle C
Ann N Y Acad Sci; 2003 May; 996():112-21. PubMed ID: 12799289
[TBL] [Abstract][Full Text] [Related]
58. High-Throughput Mapping and Clonal Quantification of Retroviral Integration Sites.
Gillet NA; Melamed A; Bangham CR
Methods Mol Biol; 2017; 1582():127-141. PubMed ID: 28357667
[TBL] [Abstract][Full Text] [Related]
59. Multiple displacement amplification enables large-scale clonal analysis following retroviral gene therapy.
Bleier S; Maier P; Allgayer H; Wenz F; Zeller WJ; Fruehauf S; Laufs S
J Virol; 2008 Mar; 82(5):2448-55. PubMed ID: 18077708
[TBL] [Abstract][Full Text] [Related]
60. Telomeric location of retroviral oncogenes in humans.
Lima-de-Faria A; Mitelman F; Blomberg J; Pfeifer-Ohlsson S
Hereditas; 1991; 114(3):207-11. PubMed ID: 1960100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
